Discovery of a RIPK2 Scaffolding Inhibitor for the Treatment of Joint Autoimmune Diseases

被引：0
|
作者：
Wlodarska, Marta [1 ]
Van Huis, Chad [2 ]
Hoss, Florian [3 ]
Meyer, Rosana [1 ]
Lu, Xiaokang [2 ]
Koelmel, Dominik [2 ]
Sanchez, Brian [2 ]
Lesch, Chuck [2 ]
Telling, Alissa [2 ]
Minns, Martin [1 ]
Mbah, Nneka [2 ]
Lacan, Isabelle [1 ]
Aversa, Robert [1 ]
Lesburg, Charles [1 ]
Yu, Carmen [2 ]
Soisson, Stephen [1 ]
Dales, Natalie [1 ]
Patrick, Darryl [1 ]
Opipari, Anthony [2 ]
Pan, Shifeng [4 ]
Franchi, Luigi [2 ]
机构：
[1] Odyssey Therapeut, Boston, MA USA
[2] Odyssey Therapeut, Ann Arbor, MI USA
[3] Odyssey Therapeut, Frankfurt, Germany
[4] Odyssey Therapeut, San Diego, CA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0061
引用
收藏
页码：102 / 103
页数：2
相关论文
共 50 条
  • [31] Discovery of a Novel p38α-MK2 Complex Inhibitor as a Potential Choice for Autoimmune Diseases
    Fu, Donglin
    Yang, Zimo
    Jia, Xiangyu
    Han, Tian
    Han, Long
    Zhang, Xiaobing
    Xia, Yuanfeng
    Wang, Siqin
    Jin, Lei
    Hu, Zhilong
    Yang, Fanglong
    JOURNAL OF MEDICINAL CHEMISTRY, 2025, 68 (02) : 1328 - 1343
  • [32] Rilonacept -: IL-1 inhibitor treatment of autoimmune diseases treatment of inflammatoty disorders
    Sorbera, L. A.
    Bozzo, J.
    Bayes, M.
    DRUGS OF THE FUTURE, 2007, 32 (05) : 411 - 416
  • [33] Discovery of Clinical Candidate GLPG3970: A Potent and Selective Dual SIK2/SIK3 Inhibitor for the Treatment of Autoimmune and Inflammatory Diseases
    Peixoto, Christophe
    Joncour, Agnes
    Temal-Laib, Taoues
    Tirera, Amynata
    Dos Santos, Aurelie
    Jary, Helene
    Bucher, Denis
    Laenen, Wendy
    Fernandes, Anna Pereira
    Lavazais, Stephanie
    Delachaume, Carole
    Merciris, Didier
    Saccomani, Corinne
    Drennan, Michael
    Lopez-Ramos, Miriam
    Wakselman, Emanuelle
    Dupont, Sonia
    Borgonovi, Monica
    Magadan, Carlos Roca
    Monjardet, Alain
    Brys, Reginald
    De Vos, Steve
    Andrews, Martin
    Jimenez, Juan-Miguel
    Amantini, David
    Desroy, Nicolas
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (07) : 5233 - 5258
  • [34] Discovery of CP-690,550: A Potent and Selective Janus Kinase (JAK) Inhibitor for the Treatment of Autoimmune Diseases and Organ Transplant Rejection
    Flanagan, Mark E.
    Blumenkopf, Todd A.
    Brissette, William H.
    Brown, Matthew F.
    Casavant, Jeffrey M.
    Shang-Poa, Chang
    Doty, Jonathan L.
    Elliott, Eileen A.
    Fisher, Michael B.
    Hines, Michael
    Kent, Craig
    Kudlacz, Elizabeth M.
    Lillie, Brett M.
    Magnuson, Kelly S.
    McCurdy, Sandra P.
    Munchhof, Michael J.
    Perry, Bret D.
    Sawyer, Perry S.
    Strelevitz, Timothy J.
    Subramanyam, Chakrapani
    Sun, Jianmin
    Whipple, David A.
    Changelian, Paul S.
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (24) : 8468 - 8484
  • [35] First-in-class inhibitor of the T cell receptor for the treatment of autoimmune diseases
    Borroto, Aldo
    Reyes-Garau, Diana
    Jimenez, M. Angeles
    Carrasco, Esther
    Moreno, Beatriz
    Martinez-Pasamar, Sara
    Cortes, Jose R.
    Perona, Almudena
    Abia, David
    Blanco, Soledad
    Fuentes, Manuel
    Arellano, Irene
    Lobo, Juan
    Heidarieh, Haleh
    Rueda, Javier
    Esteve, Pilar
    Cibrian, Danay
    Martinez-Riano, Ana
    Mendoza, Pilar
    Prieto, Cristina
    Calleja, Enrique
    Oeste, Clara L.
    Orfao, Alberto
    Fresno, Manuel
    Sanchez-Madrid, Francisco
    Alcami, Antonio
    Bovolenta, Paola
    Martin, Pilar
    Villoslada, Pablo
    Morreale, Antonio
    Messeguer, Angel
    Alarcon, Balbino
    SCIENCE TRANSLATIONAL MEDICINE, 2016, 8 (370)
  • [36] Apremilast: a novel PDE4 inhibitor in the treatment of autoimmune and inflammatory diseases
    Schett, Georg
    Sloan, Victor S.
    Stevens, Randall M.
    Schafer, Peter
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2010, 2 (05) : 271 - 278
  • [37] Discovery of a new cytosolic phospholipase A2 inhibitor as a promising drug candidate for treatment of respiratory diseases
    Terakawa, Maki
    Tomoo, Toshiyuki
    Hayashi, Yasuhiro
    Nagahira, Kazuhiro
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2016, 130 (03) : S73 - S73
  • [38] Autoimmune Rheumatic Diseases 2 Systemic lupus erythematosus and other autoimmune rheumatic diseases: challenges to treatment
    Murphy, Grainne
    Lisnevskaia, Larissa
    Isenberg, David
    LANCET, 2013, 382 (9894): : 809 - 818
  • [39] Discovery of a potent and selective c-Kit inhibitor for the treatment of inflammatory diseases
    Chen, Ning
    Burli, Roland W.
    Neira, Susana
    Hungate, Randall
    Zhang, Dawei
    Yu, Violeta
    Nguyen, Yen
    Tudor, Yanyan
    Plant, Matthew
    Flynn, Shaun
    Meagher, Kristin L.
    Lee, Matthew R.
    Zhang, Xuxia
    Itano, Andrea
    Schrag, Michael
    Xu, Yang
    Ng, Gordon Y.
    Hu, Essa
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (14) : 4137 - 4141
  • [40] Discovery of a dual CCR2/CCR5 antagonist with a superior cardiovascular profile for the treatment of autoimmune diseases
    Hughes, Robert O.
    Rogier, D. Joseph
    Devraj, Rajesh
    Xue, Chu-Biao
    Cao, Ganfeng
    Turner, Steven R.
    Morton, Philip A.
    Keys, Kelly
    Covington, Maryanne
    Bond, Brian R.
    Yu, Ying
    Meade, Holly
    Hood, William F.
    Roeberds, Steve
    Newton, Robert
    Metcalf, Brian
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
12345